Company / Accounts Receivable
Hims & Hers Health Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$32.1M
FY2025
5-year range
$3.9M / $32.1M
FY2021-FY2025
Trend
+426.2%
vs FY2024
Sector context
#123 of 138
Health Care
What the data says
Accounts Receivable changed +426% YoY in FY2025, a notable deviation from the 5-year average annual change of +151%.
Based on SEC 10-K filings.
$32M in FY2025 with a 5-year CAGR of +96.3%.
Improved from $7M to $32M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +101.9%
- 5-Year CAGR
- +96.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 138This company $32.1M Sector average $1.3B
▼
-97.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +96.3%, indicating consistent growth.
- In FY2025, accounts receivable increased 426.2% year-over-year.
- Ranks #123 out of 138 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.1M | +426.2% |
| FY2024 | $6.1M | -9.0% |
| FY2023 | $6.7M | +71.8% |
| FY2022 | $3.9M | -4.9% |
| FY2021 | $4.1M | +272.7% |
| FY2020 | $1.1M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026